OQROGet OQRO Pro
Insider trade

Travere Therapeutics (TVTX)CFO sold ~$631

Christopher R. Cline, CFO at Travere Therapeutics, sold ~$631 of Travere Therapeutics shares.

~$631
Approx. value · 48 sh @ $13.14
90K
Holds after · shares reported
Traded
Apr 11, 2025
Filed
Apr 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 6, 2025InsiderDirector sold ~$220K of TVTX shares in the open market
  2. Feb 11, 2025Insider · 3 peopleInsiders: 7 sales (~$1.7M)
  3. Feb 12, 2025Insider · 4 peopleInsiders: 4 sales (~$431K)
  4. Apr 11, 2025 · this disclosureInsiderCFO sold ~$631 of TVTX shares in the open market

What came next

  1. May 5, 2025Insider · 5 peopleInsiders: 5 sales (~$644K)
  2. Jul 1, 2025InsiderOfficer sold ~$12K of TVTX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Travere Therapeutics

For Travere Therapeutics, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 4 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TVTX page.

Other recent filings by Christopher R. Cline, CHIEF FINANCIAL OFFICER

The full history of Christopher R. Cline, CHIEF FINANCIAL OFFICER is on the profile page.

How this filing works

Explore the data

Other disclosures at Travere Therapeutics

Everything OQRO holds on this company is on its TVTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data